Moderna to develop vaccine candidates for seasonal flu HIV – MarketWatch

Shares of Moderna Inc.
MRNA,
+5.02%
were up 1.3% in premarket trading on Monday after the company said it plans to launch new development programs using its mRNA technology that will focus on d… [read more]